High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips.


Journal

Harm reduction journal
ISSN: 1477-7517
Titre abrégé: Harm Reduct J
Pays: England
ID NLM: 101153624

Informations de publication

Date de publication:
09 03 2021
Historique:
received: 09 10 2020
accepted: 26 02 2021
entrez: 22 3 2021
pubmed: 23 3 2021
medline: 30 9 2021
Statut: epublish

Résumé

The opioid epidemic has caused an increase in overdose deaths which can be attributed to fentanyl combined with various illicit substances. Drug checking programs have been started by many harm reduction groups to provide tools for users to determine the composition of their street drugs. Immunoassay fentanyl test strips (FTS) allow users to test drugs for fentanyl by either filling a baggie or cooker with water to dissolve the sample and test. The antibody used in FTS is very selective for fentanyl at high dilutions, a characteristic of the traditional use of urine testing. These street sample preparation methods can lead to mg/mL concentrations of several potential interferents. We tested whether these concentrated samples could cause false positive results on a FTS. 20 ng/mL Rapid Response FTS were obtained from BTNX Inc. and tested against 4 different pharmaceuticals (diphenhydramine, alprazolam, gabapentin, and naloxone buprenorphine) and 3 illicit stimulants [cocaine HCl, methamphetamine, and 3,4-methylenedioxymethamphetamine (MDMA)] in concentrations from 20 to 0.2 mg/mL. The FTS testing pad is divided into 2 sections: the control area and the test area. Control and test area signal intensities were quantified by ImageJ from photographs of the test strips and compared to a threshold set by fentanyl at the FTS limit of detection. False positive results indicating the presence of fentanyl were obtained from samples of methamphetamine, MDMA, and diphenhydramine at concentrations at or above 1 mg/mL. Diphenhydramine is a common cutting agent in heroin. The street sample preparation protocols for FTS use suggested by many online resources would produce such concentrations of these materials. Street samples need to be diluted more significantly to avoid interference from potential cutting agents and stimulants. Fentanyl test strips are commercially available, successful at detecting fentanyl to the specified limit of detection and can be a valuable tool for harm reduction efforts. Users should be aware that when drugs and adulterants are in high concentrations, FTS can give a false positive result.

Sections du résumé

BACKGROUND
The opioid epidemic has caused an increase in overdose deaths which can be attributed to fentanyl combined with various illicit substances. Drug checking programs have been started by many harm reduction groups to provide tools for users to determine the composition of their street drugs. Immunoassay fentanyl test strips (FTS) allow users to test drugs for fentanyl by either filling a baggie or cooker with water to dissolve the sample and test. The antibody used in FTS is very selective for fentanyl at high dilutions, a characteristic of the traditional use of urine testing. These street sample preparation methods can lead to mg/mL concentrations of several potential interferents. We tested whether these concentrated samples could cause false positive results on a FTS.
METHODS
20 ng/mL Rapid Response FTS were obtained from BTNX Inc. and tested against 4 different pharmaceuticals (diphenhydramine, alprazolam, gabapentin, and naloxone buprenorphine) and 3 illicit stimulants [cocaine HCl, methamphetamine, and 3,4-methylenedioxymethamphetamine (MDMA)] in concentrations from 20 to 0.2 mg/mL. The FTS testing pad is divided into 2 sections: the control area and the test area. Control and test area signal intensities were quantified by ImageJ from photographs of the test strips and compared to a threshold set by fentanyl at the FTS limit of detection.
RESULTS
False positive results indicating the presence of fentanyl were obtained from samples of methamphetamine, MDMA, and diphenhydramine at concentrations at or above 1 mg/mL. Diphenhydramine is a common cutting agent in heroin. The street sample preparation protocols for FTS use suggested by many online resources would produce such concentrations of these materials. Street samples need to be diluted more significantly to avoid interference from potential cutting agents and stimulants.
CONCLUSIONS
Fentanyl test strips are commercially available, successful at detecting fentanyl to the specified limit of detection and can be a valuable tool for harm reduction efforts. Users should be aware that when drugs and adulterants are in high concentrations, FTS can give a false positive result.

Identifiants

pubmed: 33750405
doi: 10.1186/s12954-021-00478-4
pii: 10.1186/s12954-021-00478-4
pmc: PMC7941948
doi:

Substances chimiques

Analgesics, Opioid 0
Illicit Drugs 0
Heroin 70D95007SX
Fentanyl UF599785JZ

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

30

Subventions

Organisme : NCATS NIH HHS
ID : UL1TR002529
Pays : United States

Références

Int J Drug Policy. 2020 Oct;84:102900
pubmed: 32769054
MMWR Morb Mortal Wkly Rep. 2020 Sep 04;69(35):1189-1197
pubmed: 32881854
Harm Reduct J. 2019 Jan 8;16(1):3
pubmed: 30621699
Harm Reduct J. 2018 Sep 10;15(1):46
pubmed: 30200991
AIDS. 2008 Aug;22 Suppl 2:S81-92
pubmed: 18641473
Am J Public Health. 2017 Mar;107(3):430-432
pubmed: 28177817
J Fam Pract. 2006 Oct;55(10):893-4, 897
pubmed: 17014756
J Anal Toxicol. 2019 Jan 1;43(1):18-24
pubmed: 30215771
Int J Drug Policy. 2020 Mar;77:102661
pubmed: 31951925
Natl Vital Stat Rep. 2019 Oct;68(12):1-16
pubmed: 32501207
Lancet. 2010 Nov 6;376(9752):1558-65
pubmed: 21036393
ACS Chem Neurosci. 2018 Oct 17;9(10):2428-2437
pubmed: 29894151
Drug Alcohol Rev. 2020 Jan;39(1):98-102
pubmed: 31746056
NCHS Data Brief. 2020 Jan;(356):1-8
pubmed: 32487285
Harm Reduct J. 2017 Jul 31;14(1):52
pubmed: 28760153

Auteurs

Tracy-Lynn E Lockwood (TE)

Department of Chemistry and Biochemistry, University of Notre Dame, 251 Stepan Hall of Chemistry, Notre Dame, IN, 46556, USA. tlockwood@nd.edu.

Alexandra Vervoordt (A)

Department of Chemistry and Biochemistry, University of Notre Dame, 251 Stepan Hall of Chemistry, Notre Dame, IN, 46556, USA.

Marya Lieberman (M)

Department of Chemistry and Biochemistry, University of Notre Dame, 251 Stepan Hall of Chemistry, Notre Dame, IN, 46556, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH